Find your next paid study

Axsome Therapeutics, Inc.NCT07766655

~$50 – $2,100

Actual pay is set by the research site.

ALS - Amyotrophic Lateral Sclerosis

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Following completion of the ALS Early Feasibility Study of the MyoRegulator® device for treatment of ALS (NCT06165172), the CALM study will further assess the …

PathMaker Neurosystems Inc.NCT06649955

Actual pay is set by the research site.

Remote eligible

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

The primary outcome measure is PIRA (progression independent of relapse activity), based primarily on clinical assessment, dichotomized as present or not. For…

Multiple Sclerosis

Northwestern UniversityNCT07207148

~$10 – $750

Actual pay is set by the research site.

Advancing Acne Care - Clinical Trials Open for Patient Enrollment

The purpose of this study is to understand the lived experiences of acne patients enrolled in a related clinical trial testing a particular treatment. The prim…

Acne

Power Life Sciences Inc.NCT07010458

Actual pay is set by the research site.

Dietary ChangeObesity & OverweightFood Acceptance

Dietary Peanut Intake and Nutrition-Related Outcomes in Individuals Using GLP-1 Receptor Agonists: A Randomized Controlled Trial

This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators …

Ian J. Neeland, MDNCT07244458

~$10 – $1,125

Actual pay is set by the research site.

Phase 3

A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared With Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients wit…

Heart Failure and Impaired Kidney Function

Degenerative Disc Disease

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06307652

Phase 3

A Prospective, Randomized, Double-Blinded, Sham-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of IDCT in Subjects With Single-Level, Symptomatic Mild to Moderate Lumbar Intervertebral Disc Degeneration

This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) intervertebral …

DiscGenics, Inc.NCT07254806

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

Randomized Phase II Study of Intermittent Versus Continuous Venetoclax Therapy With Acalabrutinib in Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This

This is a randomized Phase II study of intermittent versus continuous venetoclax therapy with Acalabrutinib in previously untreated Chronic Lymphocytic Leukemi…

Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL Variant

~$75 – $3,000

Actual pay is set by the research site.

Zulfa OmerNCT07014917

PTSDCognitive Performance

Examining the Efficacy of Short-Term Intensive PTSD Treatment on Psychological and Cognitive Impairment Symptoms

Our long-term goal is to provide rapid and sustained reductions of trauma and cognitive-related symptoms among Special Operations personnel with PTSD or subthr…

Ohio State UniversityNCT07680517

~$10 – $750

Actual pay is set by the research site.

Towards Real-time Personalized Brain State-dependent TMS to Enhance Poststroke Hand Rehabilitation

Transcranial magnetic stimulation (TMS) interventions could feasibly strengthen residual corticospinal tract (CST) connections and enhance recovery of paretic …

Stroke

~$10 – $1,125

Actual pay is set by the research site.

Sara HussainNCT06533176

Prospective Multi-Center, Single Arm, Study Evaluating the Safety and Efficacy of an ECM Hydrogel for the Treatment of Anorectal Fistulas

Safety and Efficacy of ECMT-100 for the Treatment of Anorectal Fistulas

Fistula in Ano

ECM Therapeutics, Inc.NCT07035925

Actual pay is set by the research site.

DiabetesHeart DiseasesDiet Habit+5 more

Personalized Responses to Dietary Composition Trial 3

The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to fo…